KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Evolent Health (EVH) Depreciation & Amortization (IS) (2016 - 2025)

Evolent Health has reported Depreciation & Amortization (IS) over the past 11 years, most recently at $45.0 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (IS) at $45.0 million for Q4 2025, up 53.73% from a year ago — trailing twelve months through Dec 2025 was $115.9 million (down 2.13% YoY), and the annual figure for FY2025 was $115.9 million, down 2.13%.
  • Depreciation & Amortization (IS) for Q4 2025 was $45.0 million at Evolent Health, up from $23.6 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for EVH hit a ceiling of $45.0 million in Q4 2025 and a floor of $14.9 million in Q3 2021.
  • Median Depreciation & Amortization (IS) over the past 5 years was $23.8 million (2025), compared with a mean of $24.2 million.
  • Biggest five-year swings in Depreciation & Amortization (IS): surged 112.64% in 2023 and later dropped 22.53% in 2025.
  • Evolent Health's Depreciation & Amortization (IS) stood at $15.1 million in 2021, then soared by 31.22% to $19.8 million in 2022, then skyrocketed by 49.65% to $29.6 million in 2023, then decreased by 1.03% to $29.3 million in 2024, then soared by 53.73% to $45.0 million in 2025.
  • The last three reported values for Depreciation & Amortization (IS) were $45.0 million (Q4 2025), $23.6 million (Q3 2025), and $23.1 million (Q2 2025) per Business Quant data.